Compare Nuwellis Inc (NUWE) vs Viavi Solutions Inc. Common Stock (VIAV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs Viavi Solutions Inc. Common Stock — how do they compare? Nuwellis Inc trades at $0.69 (market cap $2.20M), while Viavi Solutions Inc. Common Stock trades at $45.46 (market cap $10.85B). The key difference: Viavi Solutions Inc. Common Stock is far larger — about 4931.8× Nuwellis Inc's market cap, and Viavi Solutions Inc. Common Stock is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nuwellis Inc for 26 Days and Viavi Solutions Inc. Common Stock for 1 Days on average.
| NUWE | VIAV | |
|---|---|---|
Market Cap | $2.20M | $10.85B |
Volume | 121,544 | 4,281,289 |
Sector | Health | Technology |
52-Week High | $146.65 | $55.33 |
52-Week Low | $0.68 | $12.27 |
Typical Hold Time | 26 Days | 1 Days |
Enterprise Value | -$1.52M | $10.89B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $0.689, down 0.25% with a bearish technical signal despite oversold RSI readings. The company shows promising revenue growth (14% YoY in Q2 2026) and strong gross margins (69.69%), but faces significant profitability challenges with a -125.63% net income margin and negative cash flow. Recent news highlights console adoption growth and strategic expansions in pediatric care.
While NUWE's valuation metrics appear attractive (P/E 0.03, P/S 0.01), the company's persistent losses and negative cash flow present substantial risk. Analyst sentiment is mixed with a 50/50 buy/hold split. The stock offers speculative potential if management can achieve profitability, but requires careful risk assessment given current financial challenges.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About Viavi Solutions Inc. Common Stock
Viavi Solutions provides network testing, monitoring, and optical technologies. Its products help communications providers, equipment makers, and enterprises build and maintain networks.
Read more on VIAV →
